The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.
HIV infection has no cure but there are treatments which help to stabilize or reduce this infection so that it does not lead to AIDS. HIV therapeutics market is growing at a significant rate due to increase in the HIV infected cases and growing awareness about the same. HIV infection can be treated by various therapeutics such as nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor.
In 2017, the global HIV Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global HIV Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV Therapeutics development in United States, Europe and China.
The key players covered in this study
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited
Market segment by Type, the product can be split into
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Market segment by Application, split into
Hospitals
Clinics
Labs
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global HIV Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the HIV Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of HIV Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global HIV Therapeutics Market Size Growth Rate by Type (2013-2025)
1.4.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.4.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.4.4 Entry and Fusion Inhibitors
1.4.5 Protease Inhibitors (PIs)
1.4.6 Integrase Inhibitors
1.4.7 Coreceptor Antagonists
1.5 Market by Application
1.5.1 Global HIV Therapeutics Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Labs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 HIV Therapeutics Market Size
2.2 HIV Therapeutics Growth Trends by Regions
2.2.1 HIV Therapeutics Market Size by Regions (2013-2025)
2.2.2 HIV Therapeutics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 HIV Therapeutics Market Size by Manufacturers
3.1.1 Global HIV Therapeutics Revenue by Manufacturers (2013-2018)
3.1.2 Global HIV Therapeutics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 HIV Therapeutics Key Players Head office and Area Served
3.3 Key Players HIV Therapeutics Product/Solution/Service
3.4 Date of Enter into HIV Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global HIV Therapeutics Market Size by Type (2013-2018)
4.2 Global HIV Therapeutics Market Size by Application (2013-2018)
5 United States
5.1 United States HIV Therapeutics Market Size (2013-2018)
5.2 HIV Therapeutics Key Players in United States
5.3 United States HIV Therapeutics Market Size by Type
5.4 United States HIV Therapeutics Market Size by Application
6 Europe
6.1 Europe HIV Therapeutics Market Size (2013-2018)
6.2 HIV Therapeutics Key Players in Europe
6.3 Europe HIV Therapeutics Market Size by Type
6.4 Europe HIV Therapeutics Market Size by Application
7 China
7.1 China HIV Therapeutics Market Size (2013-2018)
7.2 HIV Therapeutics Key Players in China
7.3 China HIV Therapeutics Market Size by Type
7.4 China HIV Therapeutics Market Size by Application
8 Japan
8.1 Japan HIV Therapeutics Market Size (2013-2018)
8.2 HIV Therapeutics Key Players in Japan
8.3 Japan HIV Therapeutics Market Size by Type
8.4 Japan HIV Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia HIV Therapeutics Market Size (2013-2018)
9.2 HIV Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia HIV Therapeutics Market Size by Type
9.4 Southeast Asia HIV Therapeutics Market Size by Application
10 India
10.1 India HIV Therapeutics Market Size (2013-2018)
10.2 HIV Therapeutics Key Players in India
10.3 India HIV Therapeutics Market Size by Type
10.4 India HIV Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America HIV Therapeutics Market Size (2013-2018)
11.2 HIV Therapeutics Key Players in Central & South America
11.3 Central & South America HIV Therapeutics Market Size by Type
11.4 Central & South America HIV Therapeutics Market Size by Application
12 International Players Profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Boehringer Ingelheim International GmbH Company Details
12.1.2 Company Description and Business Overview
12.1.3 HIV Therapeutics Introduction
12.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2013-2018)
12.1.5 Boehringer Ingelheim International GmbH Recent Development
12.2 Merck & Co.
12.2.1 Merck & Co. Company Details
12.2.2 Company Description and Business Overview
12.2.3 HIV Therapeutics Introduction
12.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2013-2018)
12.2.5 Merck & Co. Recent Development
12.3 ViiV Healthcare
12.3.1 ViiV Healthcare Company Details
12.3.2 Company Description and Business Overview
12.3.3 HIV Therapeutics Introduction
12.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2013-2018)
12.3.5 ViiV Healthcare Recent Development
12.4 AbbVie
12.4.1 AbbVie Company Details
12.4.2 Company Description and Business Overview
12.4.3 HIV Therapeutics Introduction
12.4.4 AbbVie Revenue in HIV Therapeutics Business (2013-2018)
12.4.5 AbbVie Recent Development
12.5 F. Hoffmann-La Roche Ltd.
12.5.1 F. Hoffmann-La Roche Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 HIV Therapeutics Introduction
12.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2013-2018)
12.5.5 F. Hoffmann-La Roche Ltd. Recent Development
12.6 Teva Pharmaceutical Industries Ltd.
12.6.1 Teva Pharmaceutical Industries Ltd. Company Details
12.6.2 Company Description and Business Overview
12.6.3 HIV Therapeutics Introduction
12.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2013-2018)
12.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 HIV Therapeutics Introduction
12.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2013-2018)
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Gilead Sciences
12.8.1 Gilead Sciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 HIV Therapeutics Introduction
12.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2013-2018)
12.8.5 Gilead Sciences Recent Development
12.9 Johnson & Johnson
12.9.1 Johnson & Johnson Company Details
12.9.2 Company Description and Business Overview
12.9.3 HIV Therapeutics Introduction
12.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2013-2018)
12.9.5 Johnson & Johnson Recent Development
12.10 Cipla Limited
12.10.1 Cipla Limited Company Details
12.10.2 Company Description and Business Overview
12.10.3 HIV Therapeutics Introduction
12.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2013-2018)
12.10.5 Cipla Limited Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table HIV Therapeutics Key Market Segments
Table Key Players HIV Therapeutics Covered
Table Global HIV Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global HIV Therapeutics Market Size Market Share by Type 2013-2025
Figure Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Figures
Table Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Figure Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Figures
Table Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Figure Entry and Fusion Inhibitors Figures
Table Key Players of Entry and Fusion Inhibitors
Figure Protease Inhibitors (PIs) Figures
Table Key Players of Protease Inhibitors (PIs)
Figure Integrase Inhibitors Figures
Table Key Players of Integrase Inhibitors
Figure Coreceptor Antagonists Figures
Table Key Players of Coreceptor Antagonists
Table Global HIV Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Labs Case Studies
Figure HIV Therapeutics Report Years Considered
Table Global HIV Therapeutics Market Size 2013-2025 (Million US$)
Figure Global HIV Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
Table Global HIV Therapeutics Market Size by Regions 2013-2025 (Million US$)
Table Global HIV Therapeutics Market Size by Regions 2013-2018 (Million US$)
Table Global HIV Therapeutics Market Share by Regions 2013-2018
Figure Global HIV Therapeutics Market Share by Regions 2013-2018
Figure Global HIV Therapeutics Market Share by Regions 2018
Table Market Top Trends
Table Global HIV Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
Table Global HIV Therapeutics Market Share by Manufacturers (2013-2018)
Figure Global HIV Therapeutics Market Share by Manufacturers in 2018
Table Global HIV Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players HIV Therapeutics Product/Solution/Service
Table Date of Enter into HIV Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global HIV Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Global HIV Therapeutics Market Size Share by Type (2013-2018)
Figure Global HIV Therapeutics Market Size Market Share by Type (2013-2018)
Table Global HIV Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Global HIV Therapeutics Market Size Share by Application (2013-2018)
Figure Global HIV Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global HIV Therapeutics Revenue Market Share by Application in 2017
Figure United States HIV Therapeutics Market Size 2013-2018 (Million US$)
Table United States Key Players HIV Therapeutics Revenue (2017-2018) (Million US$)
Table United States Key Players HIV Therapeutics Market Share (2017-2018)
Table United States HIV Therapeutics Market Size by Type (2013-2018) (Million US$)
Table United States HIV Therapeutics Market Share by Type (2013-2018)
Table United States HIV Therapeutics Market Size by Application (2013-2018) (Million US$)
Table United States HIV Therapeutics Market Share by Application (2013-2018)
Figure Europe HIV Therapeutics Market Size 2013-2018 (Million US$)
Table Europe Key Players HIV Therapeutics Revenue (2017-2018) (Million US$)
Table Europe Key Players HIV Therapeutics Market Share (2017-2018)
Table Europe HIV Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Europe HIV Therapeutics Market Share by Type (2013-2018)
Table Europe HIV Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Europe HIV Therapeutics Market Share by Application (2013-2018)
Figure China HIV Therapeutics Market Size 2013-2018 (Million US$)
Table China Key Players HIV Therapeutics Revenue (2017-2018) (Million US$)
Table China Key Players HIV Therapeutics Market Share (2017-2018)
Table China HIV Therapeutics Market Size by Type (2013-2018) (Million US$)
Table China HIV Therapeutics Market Share by Type (2013-2018)
Table China HIV Therapeutics Market Size by Application (2013-2018) (Million US$)
Table China HIV Therapeutics Market Share by Application (2013-2018)
Figure Japan HIV Therapeutics Market Size 2013-2018 (Million US$)
Table Japan Key Players HIV Therapeutics Revenue (2017-2018) (Million US$)
Table Japan Key Players HIV Therapeutics Market Share (2017-2018)
Table Japan HIV Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Japan HIV Therapeutics Market Share by Type (2013-2018)
Table Japan HIV Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Japan HIV Therapeutics Market Share by Application (2013-2018)
Figure Southeast Asia HIV Therapeutics Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players HIV Therapeutics Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players HIV Therapeutics Market Share (2017-2018)
Table Southeast Asia HIV Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia HIV Therapeutics Market Share by Type (2013-2018)
Table Southeast Asia HIV Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia HIV Therapeutics Market Share by Application (2013-2018)
Figure India HIV Therapeutics Market Size 2013-2018 (Million US$)
Table India Key Players HIV Therapeutics Revenue (2017-2018) (Million US$)
Table India Key Players HIV Therapeutics Market Share (2017-2018)
Table India HIV Therapeutics Market Size by Type (2013-2018) (Million US$)
Table India HIV Therapeutics Market Share by Type (2013-2018)
Table India HIV Therapeutics Market Size by Application (2013-2018) (Million US$)
Table India HIV Therapeutics Market Share by Application (2013-2018)
Figure Central & South America HIV Therapeutics Market Size 2013-2018 (Million US$)
Table Central & South America Key Players HIV Therapeutics Revenue (2017-2018) (Million US$)
Table Central & South America Key Players HIV Therapeutics Market Share (2017-2018)
Table Central & South America HIV Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Central & South America HIV Therapeutics Market Share by Type (2013-2018)
Table Central & South America HIV Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Central & South America HIV Therapeutics Market Share by Application (2013-2018)
Table Boehringer Ingelheim International GmbH Company Details
Table Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2013-2018) (Million US$)
Figure Boehringer Ingelheim International GmbH Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table Boehringer Ingelheim International GmbH Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure Merck & Co. Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table Merck & Co. Recent Development
Table ViiV Healthcare Company Details
Table ViiV Healthcare Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure ViiV Healthcare Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table ViiV Healthcare Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure AbbVie Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table AbbVie Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table Teva Pharmaceutical Industries Ltd. Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table Bristol-Myers Squibb Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table Gilead Sciences Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table Johnson & Johnson Recent Development
Table Cipla Limited Company Details
Table Cipla Limited Revenue in HIV Therapeutics Business (2013-2018)(Million US$)
Figure Cipla Limited Revenue Growth Rate in HIV Therapeutics Business (2013-2018)
Table Cipla Limited Recent Development
Table Global HIV Therapeutics Market Size by Regions (Million US$) 2018-2025
Figure Global HIV Therapeutics Market Size Share by Regions (2018-2025)
Figure Global HIV Therapeutics Market Size Share by Regions in 2025
Figure United States HIV Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Europe HIV Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure China HIV Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Japan HIV Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia HIV Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure India HIV Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America HIV Therapeutics Market Size Forecast (2018-2025)(Million USD)
Table Global HIV Therapeutics Market Size by Product (2018-2025) (Million US$)
Figure Global HIV Therapeutics Market Size by Product (2018-2025)
Figure Global HIV Therapeutics Market Size by Product in 2025
Table Global HIV Therapeutics Market Size by Application (2018-2025) (Million US$)
Figure Global HIV Therapeutics Market Size by Application (2018-2025)
Figure Global HIV Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
